Triptolide inhibits proliferation and invasion of malignant glioma cells

Journal of Neuro-Oncology

Volumn 109, Issue 1, 2012, Pages 53-62

  Zhang, Haipeng ^a   Zhu, Wenbo ^a   Su, Xingwen ^a   Wu, Sihan ^a   Lin, Yuan ^a   Li, Jingjie ^a   Wang, Youqiong ^a   Chen, Jingkao ^a   Zhou, Yuxi ^a   Qiu, Pengxin ^a   Yan, Guangmei ^a   Zhao, Shujin ^b   Hu, Jun ^a   Zhang, Jingxia ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b South China Center for Innovative Pharmaceuticals   (China)

Author keywords

Cell cycle; Invasion; Malignant glioma; Proliferation; Triptolide

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 6; MICROTUBULE ASSOCIATED PROTEIN 2; PROTEIN CDC42; RAC PROTEIN; RAC1 PROTEIN; RAC2 PROTEIN; RAC3 PROTEIN; RETINOBLASTOMA PROTEIN; TRIPTOLIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CANCER INVASION; CELL CYCLE ARREST; CELL STRUCTURE; CONTROLLED STUDY; DOWN REGULATION; ENZYME INHIBITION; FEMALE; GLIOMA CELL; HUMAN; HUMAN CELL; IN VIVO STUDY; MIGRATION INHIBITION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; TUMOR GROWTH; TUMOR XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; APOPTOSIS; BLOTTING, WESTERN; BRAIN NEOPLASMS; CDC42 GTP-BINDING PROTEIN; CELL CYCLE; CELL MOVEMENT; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASES; DITERPENES; EPOXY COMPOUNDS; FEMALE; FLOW CYTOMETRY; GLIOMA; MICE; MICE, NUDE; NEOPLASM INVASIVENESS; PHENANTHRENES; RAC GTP-BINDING PROTEINS; RAC1 GTP-BINDING PROTEIN; RATS; RETINOBLASTOMA PROTEIN; TUMOR CELLS, CULTURED;

EID: 84864279690     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-012-0885-5     Document Type: Article

References (38)

1. LM DeAngelis 2001 Brain tumors N Engl J Med 344 2 114 123 11150363 10.1056/NEJM200101113440207 1:STN:280:DC%2BD3M7ksVWjtQ%3D%3D (Pubitemid 32052502)
2. MD Prados V Levin 2000 Biology and treatment of malignant glioma Semin Oncol 27 3 Suppl 6 1 10 10866344 1:STN:280:DC%2BD3czit1OisQ%3D%3D (Pubitemid 30390229)
3. EC Holland 2000 Glioblastoma multiforme: the terminator Proc Natl Acad Sci U S A 97 12 6242 6244 10841526 10.1073/pnas.97.12.6242 1:CAS:528: DC%2BD3cXktFWqurY%3D (Pubitemid 30412695)
4. RD Kortmann, et al. 2003 Radiochemotherapy of malignant glioma in adults. Clinical experiences Strahlenther Onkol 179 4 219 232 12707711 10.1007/s00066-003-1027-y (Pubitemid 36458463)
5. MK Nicholas R Lukas S Bangalore 2005 Chemotherapy for malignant glioma Expert Rev Neurother 5 6 Suppl S41 S49 16274270 10.1586/14737175.5.6.S41 1:CAS:528:DC%2BD2MXhtlamsLzK (Pubitemid 41680448)
6. BJ Chen 2001 Triptolide, a novel immunosuppressive and anti-inflammatory agent purified from a Chinese herb Tripterygium wilfordii Hook F Leuk Lymphoma 42 3 253 265 11699390 10.3109/10428190109064582 1:CAS:528:DC%2BD3MXmtlSlt7w%3D (Pubitemid 32725582)
7. XH Jiang, et al. 2001 Functional p53 is required for triptolide-induced apoptosis and AP-1 and nuclear factor-kappaB activation in gastric cancer cells Oncogene 20 55 8009 8018 11753684 10.1038/sj.onc.1204981 1:CAS:528: DC%2BD3MXptlKrsrk%3D
8. W Zhu, et al. 2009 A small-molecule triptolide suppresses angiogenesis and invasion of human anaplastic thyroid carcinoma cells via down-regulation of the nuclear factor-kappa B pathway Mol Pharmacol 75 4 812 819 19158360 10.1124/mol.108.052605 1:CAS:528:DC%2BD1MXktVSluro%3D
9. BZ Carter, et al. 2008 Triptolide sensitizes AML cells to TRAIL-induced apoptosis via decrease of XIAP and p53-mediated increase of DR5 Blood 111 7 3742 3750 18187663 10.1182/blood-2007-05-091504 1:CAS:528:DC%2BD1cXktlWmtrg%3D
10. S Yang, et al. 2003 Triptolide inhibits the growth and metastasis of solid tumors Mol Cancer Ther 2 1 65 72 12533674 1:CAS:528:DC%2BD3sXhtlOit7w%3D
11. WT Chang, et al. 2001 Triptolide and chemotherapy cooperate in tumor cell apoptosis. A role for the p53 pathway J Biol Chem 276 3 2221 2227 11053449 1:CAS:528:DC%2BD3MXotVCltw%3D%3D
12. JM Fidler, et al. 2003 PG490-88, a derivative of triptolide, causes tumor regression and sensitizes tumors to chemotherapy Mol Cancer Ther 2 9 855 862 14555704 1:CAS:528:DC%2BD3sXotVShtLs%3D
13. P Kizelsztein S Komarnytsky I Raskin 2009 Oral administration of triptolide ameliorates the clinical signs of experimental autoimmune encephalomyelitis (EAE) by induction of HSP70 and stabilization of NF-kappaB/IkappaBalpha transcriptional complex J Neuroimmunol 217 1-2 28 37 19796825 10.1016/j.jneuroim.2009.08.017 1:CAS:528:DC%2BD1MXhsVKntLnP
14. J Xie, et al. 2009 Anesthetic pentobarbital inhibits proliferation and migration of malignant glioma cells Cancer Lett 282 1 35 42 19346066 10.1016/j.canlet.2009.02.055 1:CAS:528:DC%2BD1MXotFykt7w%3D
15. Y Li, et al. 2007 Cholera toxin induces malignant glioma cell differentiation via the PKA/CREB pathway Proc Natl Acad Sci U S A 104 33 13438 13443 17679696 10.1073/pnas.0701990104 1:CAS:528:DC%2BD2sXps1Kgtbs%3D (Pubitemid 47293963)
16. CM Tsang, et al. 2009 Berberine inhibits Rho GTPases and cell migration at low doses but induces G2 arrest and apoptosis at high doses in human cancer cells Int J Mol Med 24 1 131 138 19513545 1:CAS:528:DC%2BD1MXos1Whu7o%3D
17. A Hall 1998 Rho GTPases and the actin cytoskeleton Science 279 5350 509 514 9438836 10.1126/science.279.5350.509 1:CAS:528:DyaK1cXotVKrsQ%3D%3D (Pubitemid 28067271)
18. K Kaibuchi S Kuroda M Amano 1999 Regulation of the cytoskeleton and cell adhesion by the Rho family GTPases in mammalian cells Annu Rev Biochem 68 459 486 10872457 10.1146/annurev.biochem.68.1.459 1:CAS:528:DyaK1MXlvFajsbg%3D (Pubitemid 29449200)
19. AJ Ridley, et al. 1999 Rho family proteins and cell migration Biochem Soc Symp 65 111 123 10320936 1:CAS:528:DyaK1MXitlCit7c%3D (Pubitemid 129541617)
20. S Baranwal SK Alahari 2011 Rho GTPase effector functions in tumor cell invasion and metastasis Curr Drug Targets 12 8 1194 1201 21561416 10.2174/138945011795906534 1:CAS:528:DC%2BC3MXosFahsrw%3D
21. R Wechsler-Reya MP Scott 2001 The developmental biology of brain tumors Annu Rev Neurosci 24 385 428 11283316 10.1146/annurev.neuro.24.1.385 1:CAS:528:DC%2BD3MXls1Shs78%3D (Pubitemid 32695234)
22. BK Rasheed, et al. 1999 Molecular pathogenesis of malignant gliomas Curr Opin Oncol 11 3 162 167 10328589 10.1097/00001622-199905000-00004 1:CAS:528:DyaK1MXjtF2rtrg%3D (Pubitemid 29229607)
23. WP Mason JG Cairncross 2005 Drug Insight: temozolomide as a treatment for malignant glioma-impact of a recent trial Nat Clin Pract Neurol 1 2 88 95 16932504 10.1038/ncpneuro0045 1:CAS:528:DC%2BD28Xis1Sit7w%3D
24. JE Wolff, et al. 2008 Nitrosourea efficacy in high-grade glioma: a survival gain analysis summarizing 504 cohorts with 24,193 patients J Neurooncol 88 1 57 63 18253699 10.1007/s11060-008-9533-5
25. W Gunther, et al. 2003 Temozolomide induces apoptosis and senescence in glioma cells cultured as multicellular spheroids Br J Cancer 88 3 463 469 12569392 10.1038/sj.bjc.6600711 1:STN:280:DC%2BD3s%2FlvVCgtg%3D%3D (Pubitemid 36308160)
26. R Stupp, et al. 2005 Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma N Engl J Med 352 10 987 996 15758009 10.1056/NEJMoa043330 1:CAS:528:DC%2BD2MXit1Wksbk%3D (Pubitemid 40349501)
27. NC Hank JR Shapiro AC Scheck 2006 Over-representation of specific regions of chromosome 22 in cells from human glioma correlate with resistance to 1,3-bis(2-chloroethyl)-1-nitrosourea BMC Cancer 6 2 16393339 10.1186/1471-2407-6-2 (Pubitemid 43084603)
28. J Pan 2010 RNA polymerase: an important molecular target of triptolide in cancer cells Cancer Lett 292 2 149 152 20045594 10.1016/j.canlet.2009.11.018 1:CAS:528:DC%2BC3cXkvFemtr4%3D
29. J Lin, et al. 2007 The effect of triptolide on apoptosis of glioblastoma multiforme (GBM) cells J Int Med Res 35 5 637 643 17900403 1:CAS:528: DC%2BD2sXht1WmsrzF (Pubitemid 47570485)
30. J Lin, et al. 2007 Inhibitory effect of triptolide on glioblastoma multiforme in vitro J Int Med Res 35 4 490 496 17697526 1:CAS:528: DC%2BD2sXhtVers7fJ (Pubitemid 47261111)
31. Z Wang, et al. 2009 Triptolide downregulates Rac1 and the JAK/STAT3 pathway and inhibits colitis-related colon cancer progression Exp Mol Med 41 10 717 727 19561401 10.3858/emm.2009.41.10.078 1:CAS:528:DC%2BD1MXhsVSmsLfP
32. F Zhao, et al. 2010 Triptolide alters histone H3K9 and H3K27 methylation state, and induces G0/G1 arrest and caspase-dependent apoptosis, in multiple myeloma in vitro Toxicology 267 1-3 70 79 19879315 10.1016/j.tox.2009.10.023 1:CAS:528:DC%2BD1MXhsFyntbzO
33. P Nurse 2000 A long twentieth century of the cell cycle and beyond Cell 100 1 71 78 10647932 10.1016/S0092-8674(00)81684-0 1:CAS:528: DC%2BD3cXks1Ckug%3D%3D (Pubitemid 30046296)
34. AA Schmitz, et al. 2000 Rho GTPases: signaling, migration, and invasion Exp Cell Res 261 1 1 12 11082269 10.1006/excr.2000.5049 1:CAS:528: DC%2BD3cXotVyntLo%3D
35. JB Olmsted GG Borisy 1973 Microtubules Annu Rev Biochem 42 507 540 4581232 10.1146/annurev.bi.42.070173.002451 1:CAS:528:DyaE3sXkvVygu7w%3D
36. MA Jordan L Wilson 2004 Microtubules as a target for anticancer drugs Nat Rev Cancer 4 4 253 265 15057285 10.1038/nrc1317 1:CAS:528:DC%2BD2cXis1Gmt74%3D (Pubitemid 38525281)
37. TL Gururaja, et al. 2006 R-253 disrupts microtubule networks in multiple tumor cell lines Clin Cancer Res 12 12 3831 3842 16778111 10.1158/1078-0432.CCR- 06-0168 1:CAS:528:DC%2BD28XlvVSlt7Y%3D (Pubitemid 44000265)
38. M Nakada, et al. 2007 Molecular targets of glioma invasion Cell Mol Life Sci 64 4 458 478 17260089 10.1007/s00018-007-6342-5 1:CAS:528: DC%2BD2sXjtlSrsLw%3D